Prescription for treating prostatitis and other reproductive system diseases of male
A technology for prostatitis and reproductive system, applied in the field of formula for treating prostatitis and other male reproductive system diseases
Inactive Publication Date: 2009-04-15
王莉
View PDF0 Cites 3 Cited by
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Toxicology research experiments have proved that in the acute toxicity experiment, we increased the dosage to the most concentrated level (400 times the human dosage) and still did not measure the lethal dose (LD50), which proved to be extremely safe; There is no report on the interaction between α-pandrostin and other drugs
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View moreExamples
Experimental program
Comparison scheme
Effect test
Embodiment Construction
[0009] The invention covers a variety of formulas with the same ratio, which are used to treat prostatitis and other male reproductive system diseases. The main effective ingredient used is alpha-mangostin, and its content ranges from 2% to 99.8% of the dose, and with appropriate fillers, it is made into a new product with anti-inflammatory and analgesic properties. The main diseases treated are: prostatitis, vas deferens, orchitis, urethritis, etc. The content of saccharin is 3mg-300mg, and the product can be made into 50mg-1000mg tablets or capsules or other dosage forms for convenient consumption.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More PUM
Login to View More Abstract
The invention relates to a formula for treating prostatitis and other male reproductive system diseases. The invention discloses a main compound extracted from mangosteen: Garcinia Mangostana, wherein alpha-mangostin is taken as a main effective constituent and mixed with various commonly used fillers in the medicine industry to prepare various appropriate preparation formulations including tablets, capsules, powder, and suppository; and the various preparation formulations can be used for preventing and treating male reproductive system inflammations such as prostatitis, orchitis, deferentitis and urethritis by means of oral taking or external application. The content of the alpha-mangostin in the product is between 3 and 99.8 percent; and the prepared product can relieve various inflammations, has the function of relieving pain to certain degree, and can be independently used or mixed with other natural substances for use.
Description
Technical field: [0001] Prostatitis is a common disease in adult males, accounting for about 25% to 30% of outpatient diseases in urology department according to general statistics. Infect. Acute prostatitis mostly has a sudden onset, with symptoms such as frequent urination, urgency, and painful urination. Chronic prostatitis is not so simple. It has many symptoms, mainly pain or discomfort, and sometimes urinary tract irritation symptoms. Severe prostatitis Inflammation patients also have symptoms such as lack of energy, fatigue, dizziness and tinnitus. [0002] Currently, for the treatment of prostatitis and other male reproductive system diseases, commonly used non-steroidal (non-steroidal) anti-inflammatory drugs (NSAIDs) have side effects to varying degrees. The most common adverse reactions of NSAIDs include gastrointestinal damage, liver and kidney damage, effects on the blood system, symptoms of the central nervous system, and allergic reactions. Gastrointestinal r...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More Application Information
Patent Timeline
Login to View More Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/185A61P13/02A61P13/08A61P15/00A61K31/352
Inventor 王莉
Owner 王莉
PatSnap Eureka turns technology decisions into work you can execute. Powered by our Innovation Knowledge Graph, it runs expert workflows across engineering, life sciences, materials and intellectual property. Get your review-ready output in minutes.
